The serum concentration of Alprazolam can be increased when it is combined with Candoxatril. The serum concentration of Alprazolam can be increased when it is combined with Cilazapril. The metabolism of Alprazolam can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Ethylmorphine. The serum concentration of Alprazolam can be increased when it is combined with Dasabuvir. The serum concentration of Alprazolam can be increased when it is combined with Fluvoxamine. The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin. The serum concentration of Alprazolam can be increased when it is combined with Linagliptin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Chlorprothixene. The risk or severity of adverse effects can be increased when Alprazolam is combined with Ethotoin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Flibanserin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Lofentanil. The serum concentration of Alprazolam can be decreased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Alprazolam is combined with Vortioxetine. The metabolism of Alprazolam can be decreased when combined with Venlafaxine. The metabolism of Alprazolam can be decreased when combined with Ziprasidone. The risk or severity of adverse effects can be increased when Alprazolam is combined with Chloral hydrate. The serum concentration of Alprazolam can be increased when it is combined with Captopril. The serum concentration of Alprazolam can be increased when it is combined with Spirapril. The metabolism of Alprazolam can be decreased when combined with Sulfisoxazole. The metabolism of Alprazolam can be decreased when combined with Dosulepin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Aripiprazole. The serum concentration of Alprazolam can be increased when it is combined with Alpha-1-proteinase inhibitor. The risk or severity of adverse effects can be increased when Alprazolam is combined with Methadyl Acetate. The serum concentration of Alprazolam can be increased when it is combined with Ombitasvir. The serum concentration of Alprazolam can be increased when it is combined with Enalkiren. The risk or severity of adverse effects can be increased when Alprazolam is combined with Ketamine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Butamben. The serum concentration of Alprazolam can be increased when it is combined with Ivacaftor. The risk or severity of adverse effects can be increased when Alprazolam is combined with Olanzapine. The serum concentration of Alprazolam can be increased when it is combined with Phosphoramidon. The risk or severity of adverse effects can be increased when Alprazolam is combined with Etizolam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Oxycodone. The serum concentration of Rilpivirine can be increased when it is combined with Alprazolam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Lidocaine. Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. The serum concentration of Tolvaptan can be increased when it is combined with Alprazolam. Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. The risk or severity of adverse effects can be increased when Alprazolam is combined with 7-Nitroindazole. The risk or severity of adverse effects can be increased when Butabarbital is combined with Alprazolam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Articaine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Risperidone. Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. The risk or severity of adverse effects can be increased when Alprazolam is combined with Diphenhydramine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Indiplon. The metabolism of Alprazolam can be decreased when combined with Midostaurin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Alaproclate. The risk or severity of adverse effects can be increased when Alprazolam is combined with Brexpiprazole. The risk or severity of adverse effects can be increased when Alprazolam is combined with Adipiplon. The serum concentration of Alprazolam can be increased when it is combined with Vildagliptin. The serum concentration of Alprazolam can be increased when it is combined with Quinapril. The serum concentration of Alprazolam can be increased when it is combined with Palbociclib. The risk or severity of adverse effects can be increased when Alprazolam is combined with Tetrahydropalmatine. The metabolism of Alprazolam can be decreased when combined with Fluvastatin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Guanfacine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Haloperidol. The risk or severity of adverse effects can be increased when Morphine is combined with Alprazolam. The serum concentration of Alprazolam can be increased when it is combined with Gabexate. The serum concentration of Alprazolam can be increased when it is combined with Indinavir. The metabolism of Alprazolam can be decreased when combined with Etravirine. The metabolism of Alprazolam can be decreased when combined with Olaparib. The serum concentration of Alprazolam can be decreased when it is combined with Mitotane. The risk or severity of adverse effects can be increased when Alprazolam is combined with Allopregnanolone. The risk or severity of adverse effects can be increased when Alprazolam is combined with Bupivacaine. The serum concentration of Alprazolam can be increased when it is combined with Atazanavir. Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. The risk or severity of adverse effects can be increased when Alprazolam is combined with Buspirone. The metabolism of Alprazolam can be decreased when combined with Delavirdine. The metabolism of Alprazolam can be decreased when combined with Doxycycline. The metabolism of Alprazolam can be decreased when combined with Ranolazine. Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Alprazolam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Topiramate. The risk or severity of adverse effects can be increased when Alprazolam is combined with Zonisamide. The risk or severity of adverse effects can be increased when Alprazolam is combined with Dyclonine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Dihydrocodeine. The serum concentration of Alprazolam can be increased when it is combined with Benazepril. The risk or severity of adverse effects can be increased when Alprazolam is combined with Pizotifen. The risk or severity of adverse effects can be increased when Alprazolam is combined with DPDPE. The risk or severity of adverse effects can be increased when Alprazolam is combined with Amisulpride. The serum concentration of Alprazolam can be increased when it is combined with Ribociclib. The serum concentration of Alprazolam can be increased when it is combined with Cholesterol. The risk or severity of adverse effects can be increased when Alprazolam is combined with Duloxetine. The therapeutic efficacy of Alprazolam can be decreased when used in combination with Ambroxol acefyllinate. The serum concentration of Fosphenytoin can be increased when it is combined with Alprazolam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Brompheniramine. The metabolism of Alprazolam can be decreased when combined with Nilotinib. The risk or severity of adverse effects can be increased when Alprazolam is combined with Pimozide. The risk or severity of adverse effects can be increased when Alprazolam is combined with Ondansetron. The risk or severity of adverse effects can be increased when Alprazolam is combined with Loprazolam. The therapeutic efficacy of Alprazolam can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Fludiazepam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Dexmedetomidine. The serum concentration of Alprazolam can be increased when it is combined with Luliconazole. The therapeutic efficacy of Alprazolam can be decreased when used in combination with Hyaluronidase. The risk or severity of adverse effects can be increased when Alprazolam is combined with Promethazine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Alfaxalone. The risk or severity of adverse effects can be increased when Alprazolam is combined with Levomilnacipran. The risk or severity of adverse effects can be increased when Alprazolam is combined with Ecgonine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Vigabatrin. The serum concentration of Alprazolam can be increased when it is combined with Ulinastatin. The risk or severity of adverse effects can be increased when Alprazolam is combined with Amobarbital. The risk or severity of adverse effects can be increased when Alprazolam is combined with Ketobemidone. The serum concentration of Alprazolam can be increased when it is combined with Telithromycin. The serum concentration of Alprazolam can be decreased when it is combined with Lumacaftor. The risk or severity of adverse effects can be increased when Alprazolam is combined with Quazepam. The risk or severity of adverse effects can be increased when Alprazolam is combined with Amperozide. The risk or severity of adverse effects can be increased when Alprazolam is combined with Butalbital. The metabolism of Alprazolam can be decreased when combined with Fluorouracil. The risk or severity of adverse effects can be increased when Alprazolam is combined with Zuclopenthixol. The serum concentration of Alprazolam can be increased when it is combined with Enalaprilat. The risk or severity of adverse effects can be increased when Tramadol is combined with Alprazolam. The metabolism of Alprazolam can be decreased when combined with Atomoxetine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Mesoridazine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Desflurane. The risk or severity of adverse effects can be increased when Alprazolam is combined with Aceprometazine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Procaine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Olopatadine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Pipotiazine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Indalpine. The metabolism of Alprazolam can be decreased when combined with Amiodarone. The serum concentration of Alprazolam can be increased when it is combined with Fosinopril. The risk or severity of adverse effects can be increased when Alprazolam is combined with Desloratadine. The serum concentration of Alprazolam can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The serum concentration of Alprazolam can be increased when it is combined with Solithromycin. The metabolism of Alprazolam can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Alprazolam is combined with Cyclizine. The risk or severity of adverse effects can be increased when Alprazolam is combined with Benzyl alcohol. The risk or severity of adverse effects can be increased when Alprazolam is combined with Thiopental. The risk or severity of adverse effects can be increased when Alprazolam is combined with Dezocine.